Sarcalumenin Activators
Sarcalumenin activators represent a diverse set of chemical compounds that influence the functionality of Sarcalumenin via indirect mechanisms involving the modulation of intracellular signaling cascades. For instance, Isoproterenol, Forskolin, Caffeine, and Epigallocatechin Gallate (EGCG) all lead to elevated cAMP levels, which in turn activate protein kinase A (PKA). PKA is well-documented to phosphorylate various proteins within the sarco/endoplasmic reticulum, increasing the calcium-binding capacity of Sarcalumenin, thus enhancing its pivotal role in calcium regulation within muscle cells. Similarly, phosphodiesterases such as IBMX, Rolipram, Milrinone, Cilostazol, Zaprinast, and Vinburnine prevent the degradation of cAMP, resulting in sustained PKA activation. The consequent phosphorylation events are likely to augment Sarcalumenin's function, improving its ability to manage calcium storage and release, which are crucial for muscle contraction and relaxation dynamics. Additionally, beta-adrenergic agonists like Terbutaline and Dobutamine specifically target cardiac muscle cells, increasing intracellular cAMP and thereby activating PKA, which is assumed to enhance the phosphorylation state of Sarcalumenin, facilitating its role in cardiac muscle contractility and rhythmicity.
The biochemical impact of these activators on Sarcalumenin is significant as it underscores the importance of secondary messenger systems and kinase signaling in modulating the protein's activity. The intricate crosstalk between adenylate cyclase activity, cAMP levels, and PKA activation illustrates the complex regulatory networks that govern muscle physiology. The chemical activators not only underscore the role of Sarcalumenin in calcium homeostasis but also highlight of targeting these pathways to influence Sarcalumenin activity indirectly. By leveraging the specificity of these chemicals to influence particular signaling pathways, the functional activity of Sarcalumenin is enhanced, reinforcing its essential function in the sarcoplasmic reticulum of both skeletal and cardiac muscle fibers. Through these mechanisms, the activators collectively serve to augment the efficiency of calcium handling by Sarcalumenin, ensuring optimal muscle performance and health without necessitating changes in its expression levels or direct activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a synthetic catecholamine and beta-adrenergic agonist that increases intracellular cAMP. The elevation of cAMP can lead to the activation of protein kinase A (PKA), which is known to phosphorylate multiple targets within the sarco/endoplasmic reticulum, potentially increasing the calcium-binding capacity of Sarcalumenin and enhancing its role in calcium regulation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is an activator of adenylate cyclase, leading to increased levels of cAMP in cells. This rise in cAMP activates PKA, which then may indirectly enhance the activity of Sarcalumenin by increasing its affinity for calcium in the sarcoplasmic reticulum of muscle cells, thus influencing muscle relaxation and contraction cycles. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine, by antagonizing adenosine receptors, causes an increase in intracellular cAMP via adenylate cyclase activation. Elevated cAMP levels result in the activation of PKA, which could then phosphorylate and enhance Sarcalumenin activity, indirectly augmenting its calcium sequestration role in the sarcoplasmic reticulum. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a catechin found in green tea with various biological activities. One of its effects is the inhibition of phosphodiesterases, leading to an increase in cAMP levels. The consequent activation of PKA may lead to phosphorylation events that enhance the function of Sarcalumenin, possibly increasing calcium handling and storage in muscle cells. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, which prevents the breakdown of cAMP. The resulting rise in cAMP can activate PKA, thereby potentially enhancing the phosphorylation and function of Sarcalumenin, which in turn could improve its calcium modulatory role in muscle cells. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective phosphodiesterase-4 inhibitor that increases cellular cAMP levels. Increased cAMP activates PKA, which may enhance Sarcalumenin function by promoting its phosphorylation. This enhancement could improve Sarcalumenin's capacity to sequester calcium in the sarcoplasmic reticulum, thus indirectly activating it. | ||||||
Milrinone | 78415-72-2 | sc-201193 sc-201193A | 10 mg 50 mg | $165.00 $697.00 | 7 | |
Milrinone is a phosphodiesterase inhibitor with a cardiac inotropic effect. By increasing cAMP levels and PKA activation, Milrinone could indirectly enhance Sarcalumenin activity by improving calcium sequestration in cardiac muscle, which is a key process in muscle contraction and relaxation. | ||||||
Cilostazol | 73963-72-1 | sc-201182 sc-201182A | 10 mg 50 mg | $109.00 $322.00 | 3 | |
Cilostazol is a selective inhibitor of phosphodiesterase type 3, leading to increased cAMP levels. The resulting PKA activation could enhance Sarcalumenin's role in calcium handling by potentially increasing its phosphorylation status, which is important for its function in the sarcoplasmic reticulum of muscle cells. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast is a selective inhibitor of phosphodiesterase type 5, increasing cAMP levels. This elevation of cAMP could activate PKA, which may indirectly enhance the function of Sarcalumenin, potentially improving its role in calcium regulation within muscle cells. | ||||||
Terbutaline Hemisulfate | 23031-32-5 | sc-204911 sc-204911A | 1 g 5 g | $92.00 $378.00 | 2 | |
Terbutaline is a beta2-adrenergic agonist that increases intracellular cAMP levels, leading to PKA activation. This activation could enhance Sarcalumenin function by promoting its phosphorylation, facilitating better calcium storage and release in muscle cells. | ||||||